For those who question Andrew Kolodny’s grasp of drugs and pharmacology, his latest op-ed
kratom
In a just published perspective piece in The New England Journal of Medicine, U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D.
A new press announcement released by FDA commissioner Scott Gottlieb is going to hit a lot of nerves, many of which are already raw.
